NeoRich BioPharma Tech Co., Limited (NRBP)

Market Cap	293.82K -76.7%
Revenue (ttm)	3.00K -29.1%
Net Income	-226.26K
EPS	-0.68
Shares Out	345.67K
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,258
Open	0.8500
Previous Close	0.7200
Day's Range	0.8500 - 0.8500
52-Week Range	0.1315 - 7.0000
Beta	1.84
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NeoRich BioPharma Tech

NeoRich BioPharma Tech Co., Limited operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company’s primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its pro...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Peter Wojcik
• Country: United States
• Stock Exchange: OTCMKTS
• Ticker Symbol: NRBP

Financial Performance

In fiscal year 2024, NeoRich BioPharma Tech's revenue was $3,410, an increase of 13.74% compared to the previous year's $2,998. Losses were -$1.00 million, 76.6% more than in 2023.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 7, 2026

Data Sources Report a data error